Dragon Pharma LL-37 5 mg is supplied as a lyophilized powder in a 2 mL vial and contains the human antimicrobial peptide LL-37 at a labeled strength of 5 mg/vial. Product specifications, storage information, and other practical product details are provided below.
5 mg/Vial Strength
Each vial is labeled at 5 mg of LL-37 peptide.
2 mL Vial
Supplied as a lyophilized powder in a sealed 2 mL vial.
Lyophilized Form
Supplied as a freeze-dried powder for reconstitution with bacteriostatic water or suitable diluent.
Dragon Pharma
Manufactured and packaged under the Dragon Pharma product line.
Product Specifications
Product name
LL-37 5 mg
Active substance
LL-37
Labeled strength
5 mg/vial
Container
2 mL vial
Product form
Lyophilized powder
Manufacturer
Dragon Pharma
Related Products
Other peptide research products available from Dragon Pharma include BPC-157 5 mg, a peptide investigated for tissue repair, and TB-500 5 mg, a peptide related to actin regulation. Each has a distinct research profile and mechanism of action.
Science & Research
Understanding LL-37
LL-37 is the only member of the cathelicidin family of antimicrobial peptides found in humans. It is a 37-amino-acid peptide that plays a critical role in the innate immune system, exhibiting broad-spectrum antimicrobial activity against bacteria, viruses, and fungi, as well as immunomodulatory functions.
1
Host Defense Peptide
LL-37 is a human cathelicidin antimicrobial peptide that serves as a component of the innate immune response.
2
Multifunctional Activity
LL-37 exhibits antimicrobial, immunomodulatory, and wound-healing properties in laboratory studies.
3
Membrane Disruption
LL-37 disrupts microbial membranes through pore formation, leading to cell death, while also modulating host immune responses.
Mechanism of Action
LL-37 is a human antimicrobial peptide that serves as a key component of the innate immune system. It is produced by various cell types, including epithelial cells and immune cells, and is found in many tissues throughout the body.
The peptide has a dual mechanism of action. It directly disrupts microbial membranes through pore formation, leading to microbial cell death. In addition, LL-37 has immunomodulatory properties, including the ability to neutralize bacterial toxins, modulate inflammatory responses, and promote wound healing. These diverse functions make LL-37 a subject of significant research interest in immunology and infectious disease.
Research Context
LL-37 has been studied in various research contexts, including its role in host defense against pathogens, its immunomodulatory functions, and its potential relevance to wound healing and inflammatory conditions.
Dragon Pharma LL-37 5 mg is supplied as a lyophilized powder in a 2 mL vial at a labeled strength of 5 mg/vial.
Research References
LL-37 has been the subject of extensive research investigating its properties and biological functions.
LL-37 is a research peptide with limited safety data in humans. As a bioactive peptide involved in immune modulation and antimicrobial activity, its use requires careful consideration of potential physiological effects.
Immune Modulation
LL-37 has immunomodulatory properties that may influence inflammatory responses. The full scope of these effects is not fully characterized.
Injection Site Reactions
Reconstituted peptides may cause localized reactions at the injection site. Proper aseptic technique is essential for preparation and administration.
Pregnancy and Breastfeeding
LL-37 is not indicated for use during pregnancy or breastfeeding. Its effects on fetal development and infant health are not established.
Unknown Risks
As a research compound, the long-term safety profile of LL-37 is not fully established. Unknown risks may exist.
Conditions That Require Medical Review
Medical advice is particularly important when there is a history of autoimmune conditions, inflammatory disorders, or when taking medications that may interact with immune pathways.
The product should also be stored securely to prevent accidental access or use by children or other household members.
When to Seek Urgent Medical Help
Seek urgent medical attention for symptoms such as severe allergic reactions, chest pain, sudden shortness of breath, fainting, or signs of a serious adverse reaction.
Tested Sport
LL-37 is not currently listed on the WADA Prohibited List. However, the use of peptides and research compounds may be subject to specific anti-doping rules depending on the sport and governing body. Current requirements should be checked against the relevant anti-doping rules before competition.
Quick answers about LL-37 5 mg specifications, storage, shipping, Bitcoin payment and general product information.
What is Dragon Pharma LL-37 5 mg?
Dragon Pharma LL-37 5 mg is a lyophilized peptide product containing LL-37 at a labeled strength of 5 mg per vial. It is supplied in a 2 mL vial as a freeze-dried powder.
What is LL-37?
LL-37 is the only human cathelicidin antimicrobial peptide. It is a 37-amino-acid peptide that plays a critical role in the innate immune system, exhibiting antimicrobial activity against bacteria, viruses, and fungi, as well as immunomodulatory functions.
How is LL-37 5 mg supplied?
It is supplied as a lyophilized powder in a 2 mL vial. The product must be reconstituted with a suitable diluent such as bacteriostatic water before use in a research setting.
What is the cathelicidin family?
Cathelicidins are a family of antimicrobial peptides found in many species. LL-37 is the only cathelicidin peptide found in humans. These peptides are important components of the innate immune system.
Is LL-37 5 mg FDA approved?
No. LL-37 is not FDA-approved for any therapeutic use. It is a research compound intended for laboratory and preclinical research purposes only.
How should LL-37 5 mg be stored?
Keep the lyophilized powder in its original packaging and protect it from excessive heat, moisture and direct light. Refer to the product label for specific storage directions regarding temperature and shelf life. Once reconstituted, the solution should be used promptly or stored according to the manufacturer's directions.
Does LL-37 5 mg require refrigeration?
Follow the storage instructions printed on the supplied product. Lyophilized peptides often require refrigeration, but specific storage conditions should be verified from the product label.
How long does LL-37 5 mg delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy LL-37 5 mg with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy LL-37 5 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is LL-37 permitted in tested sport?
LL-37 is not currently listed on the WADA Prohibited List. However, the use of peptides and research compounds may be subject to specific anti-doping rules depending on the sport and governing body. Current requirements should be checked against the relevant anti-doping rules before competition.
Where can I find more information about LL-37?
Additional information about LL-37 is available through PubMed and other research literature databases. Direct links are provided in the Science & Research section above.
